Dr Charlie Davie is standing down as Managing Director of UCLPartners to focus on his new role as Director of DATA-CAN: The Health Data Research Hub for Cancer, a national initiative hosted at UCLPartners.
Professor Mike Roberts is stepping into the role of interim UCLPartners Managing Director, ahead of a process to recruit into the substantive role next year. Mike has been director of a number of programmes at UCLPartners since 2011 and brings extensive clinical and academic expertise to the role.
He has led UCLPartners AHSN since July 2019, alongside his roles as Integrated Care Respiratory Physician at Princess Alexandra NHS Trust, Professor of Medical Education for Clinical Practice at Queen Mary University of London, and Implementation Lead at NIHR North Thames ARC.
Rt. Hon. Professor Lord Kakkar, PC, Chair of UCLPartners, said: “I would like to thank Charlie for his leadership at UCLPartners through a variety of different roles since its inception in 2009, and for his unwavering commitment to our mission and values. His leadership of this new cancer data initiative, hosted by UCLPartners, provides new opportunities for us to contribute to an important national effort to harness health data to improve cancer care, in our region and across the UK. I am delighted that Mike is able to step into the interim MD role, bringing his extensive clinical leadership experience and strong academic and clinical connections.”
Dr Charlie Davie said: “I feel privileged to have been able to lead work at UCLPartners over many years and to work with partners from across the NHS, academia and industry to improve clinical care and patient outcomes. I look forward to continuing to work as part of UCLPartners as DATA-CAN Director to develop informatics opportunities across our partnership.”
Professor Mike Roberts said: “We have a clear commitment across UCLPartners to working together across our region to harness research and innovation for the benefit of patients. I look forward to continuing to work with our team and our partners in my new role over the coming months.”